Improved graft function using a new myocardial preservation solution: Celsior. Preliminary data from a randomized prospective study

Transplantation Proceedings

Volumn 31, Issue 5, 1999, Pages 2067-2068

  Wieselthaler, G M ^b   Chevtchik, O ^b   Konetschny, R ^b   Moidl, R ^b   Mallinger, R ^b   Mares, P ^b   Griessmacher, A ^a   Grimm, M ^b   Wolner, E ^b   Laufer, G ^b  

^a KAISER FRANZ JOSEF HOSPITAL   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELSIOR; HTK SOLUTION; PRESERVATION SOLUTION; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GRAFT FAILURE; GRAFT PRESERVATION; GRAFT SURVIVAL; HEART PRESERVATION; HEART TRANSPLANTATION; HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; SINUS RHYTHM;

ADULT; DISACCHARIDES; ELECTROLYTES; GLUCOSE; GLUTAMATES; GLUTATHIONE; HEART TRANSPLANTATION; HISTIDINE; HUMANS; MANNITOL; MIDDLE AGED; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; POTASSIUM CHLORIDE; PROCAINE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0032792434     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(99)00264-X     Document Type: Article

References (3)

1. Hosenpud J.D., Bennett L.E., Keck B.M., et al. J Heart Lung Transplant. 16:1997;691.
2. Menasche P., Pradier F., Grousset C., et al. J Thorac Cardiovasc Surg. 105:1993;353.
3. Kormos R.L., Gasior T.A., Kawai A., et al. J Thorac Cardiovasc Surg. 111:1996;773.